6Danesh FR,Sadeghi MM,Amro N,et al.3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-indluced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway:Implications for diabetic nephropathy.Proc Natl Acad Sci US,2002,99:8301-8305.
7Goppelt-struebe M,Halhn A,Iwanciw D,et al.Regulation of connective tissue growth factor (ccn 2 ; ctgf) gene expression in human mesangial cells:modulation by HMG-CoA reductase inhibitors(statins).Mol Pathol,2001,54:176-179.
9Yang T,Chen JW,Liu CP.Combination of simvastatin and cilazapril have preventive effect on diabetic nephropathy in diabetic rat and cultured mesangial cells.Diabetologia,2001,44(suppl):A 265.
10Sunekawa T,Hayash i T,Kano H,et al.Cerivastatin,ahydroxymethylglutaryl coenzyme a reductase inhibitor,improves endothelial function in elderly diabetic patients with in 3 days.Circulation,2001,104:376-379.
2[2]Dubois D,Chanson P,Timsit J, et al.Remission of proteinuriafollowing corection of yperlipidemia in NIDDM patients with nondiabetic glomerulopathy.DIabetes Care 1994;17:906.
3Nakamura T, Ushiyama C, Hirokwa K, et al. Effect of cerivastatin on urinary albumin excretion and plasma endothelin- 1 concentations in type2 diabetes patients with microalbuminuria and dyslipidemia. Am J Nephrol, 2001,21(6) :449 - 454.
4Kim SI, Hah DC,Lee HB. Lovastatin inhibits transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J Am Soc Nephrol,2000,11(1):80-87.
5Ota T, Takamura T, Ando E, et al. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetdogia, 2003,46 (6): 843 - 851.
6Lee TM, Su SF, Tsai CH. Effect of pravastatin on proteinuria in patients with well- controlled hypertension. Hypertension, 2002,40 ( 1 ): 67 - 73.
7Tesar V. Some important news in clinical nephrology in years 2003 - 2004. Vnitr Lek, 2004,50 (Suppl 1 ): 81 - 87.
8Aika M, Rabikin E, Sugivama S, et al. An HMGCOA reductase inhibitor,cerivas- tatin,suppresses growth of macrophage expressing matrix metalloproteinases, and tissue factor in vivo and in vitro. Circulation, 2001,103:276 - 283.
9Elisaf M, Mikhailidis DP. Statins and renal function. Angiology,2002,53(5) :493 - 502.
10EpsteinM, Campese VM. Pleiotropic effects of 3 - hydroxy-3- methylglutary coenzyme a reductase inhisitors on renal funtion. Am J Kidney Dis, 2005,45 (1): 2 - 14.
